CMS
  • Partnering
  • Contact
    • Contact Information
    • Join Us
  • EN
  • CN
  • About Us
    • CMS Overview
    • Leadership
    • Milestones
    • Social Responsibility
  • Innovation
    • R&D Overview
    • Pipeline
  • Business
    • Business Overview
    • Cardio-cerebrovascular and Gastroenterology
    • Dermatology and Medical Aesthetics
    • Ophthalmology
    • Southeast Asia Business
  • News
    • Company News
    • Partner News
  • Investors
    • Stock Infomation
    • Financial Highlights
    • Information Disclosure
    • Corporate Governance
    • Investor Communication
  • Home
  • About Us
    • CMS Overview
    • Leadership
    • Milestones
    • Social Responsibility
  • Innovation
    • R&D Overview
    • Pipeline
  • Business
    • Business Overview
    • Cardio-cerebrovascular and Gastroenterology
    • Dermatology and Medical Aesthetics
    • Ophthalmology
  • News
    • Company News
    • Partner News
  • Investors
    • Investors
    • Stock Infomation
    • Financial Highlights
    • Information Disclosure
    • Corporate Governance
    • Investor Communication
  • Partnering
  • Contact
    • Contact Information
    • Join Us
  • EN
  • CN
Won the BIVA “Best Investment Value Award for Listed Companies”
2022-07-08

Won the BIVA “Best Investment Value Award for Listed Companies”

Won the “Most Valuable Pharmaceutical Listing Company” from Golden Hong Kong Listed Companies
2022-07-15

Won the “Most Valuable Pharmaceutical Listing Company” from Golden Hong Kong Listed Companies

Shenzhen Kangzhe was awarded “Top 100 Enterprises in Shenzhen” and “Top Ten Health Innovation Enterprises” by M.D. Weekly
2022-07-08

Shenzhen Kangzhe was awarded “Top 100 Enterprises in Shenzhen” and “Top Ten Health Innovation Enterprises” by M.D. Weekly

Obtained the exclusive right to commercialize Plendil in Mainland China

Obtained the exclusive right to commercialize Plendil in Mainland China

  • About Us
    • CMS Overview
    • Leadership
    • Milestones
    • Social Responsibility
  • Innovation
    • R&D Overview
    • Pipeline
  • Business
    • Business Overview
    • Cardio-cerebrovascular and Gastroenterology
    • Dermatology and Medical Aesthetics
    • Ophthalmology
    • Southeast Asia Business
  • News
    • Company News
    • Partner News
  • Investors
    • Stock Infomation
    • Financial Highlights
    • Information Disclosure
    • Corporate Governance
    • Investor Communication
  • Privacy
  • Terms Of Use
All rights reserved by CMS Group 2001-2022 ERP of CMS Group
互联网药品信息服务资格证书编号:(粤)-非经营性-2021-0109| 粤ICP备18157737号| 粤公网安备 44030502003605号